Skip to main content Skip to main navigation menu Skip to site footer

Pro and Anti-Inflammatory Factors in Patients with Rhegmatogenous Retinal Detachment with Silicone Oil Tamponade

  • Ahdini Zulfiana Abidin ,
  • Budu ,
  • Andi Muhammad Ichsan ,
  • Habibah Setyawati Muhiddin ,
  • Hasnah Eka ,

Abstract

Introduction: Rhegmatogenous retinal detachment (RRD) is the most common type of detachment, followed by exudative and tractional detachment. Pathogenic changes in the retina (including angiogenesis and fibrosis) trigger local inflammation and infiltration of leukocytes of the choroid, retina, and vitreous, which is also found in proliferative vitreoretinal detachment. Silicone oil, as a temporary tamponade used in the RRD, can cause immunological reactions in the tissue and may become one of the causes of increasing levels of inflammatory mediators in the eye. This literature review aims to determine the pro- and anti-inflammatory factors found in patients with RRD and patients with silicone oil tamponade.

Methods: This literature review utilised reliable databases such as Pubmed, Proquest, and Google Scholar from 2013 until 2023. The main keywords “rhegmatogenous retinal detachment” and “silicone oil” were used, including some additional keywords, to collect eight journals that had relevant topics.

Result: Variations of inflammatory markers were found in many studies, and some correlated with proliferative vitreoretinopathy (PVR) development, the extent of detachment and the recurrence of redetachment in some cases.

Conclusion: A rise in various cytokines can mediate the wound-healing process in RRD, specifically involving retinal pigment epithelium and glial cells, fibroblasts, and inflammatory cells in eyes with retinal tears. This trend of high activity of RPE cells also appeared in eyes with vitreous cavities replaced by silicone oil (SO). The selection of tamponade preference should be based on the extent of the injury, patients’ needs, and surgeons’ expertise.

References

  1. Cantor LB, Rapuano CJ, Cioffi GA. Basic and Clinical Science Course: Glaucoma. 10th ed. San Franscisco: American Academy of Ophthalmology; 2018. 1–16 p.
  2. Yoshimura T, Sonoda K-H, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, et al. Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases. PLoS One. 2009;4(12):e8158.
  3. Ohji M. Unexpected complications related to tamponade after vitrectomy. Vol. 254, Graefe’s Archive for Clinical and Experimental Ophthalmology. Springer Verlag; 2016. p. 1463–4.
  4. Colthurst MJ, Williams RL, Hiscott PS, Grierson I. Biomaterials used in the posterior segment of the eye. Biomaterials. 2000;21(7):649–65.
  5. Su X, Tan MJ, Li Z, Wong M, Rajamani L, Lingam G, et al. Recent Progress in Using Biomaterials as Vitreous Substitutes. Biomacromolecules. 2015;16(10):3093–102.
  6. Yadav I, Purohit SD, Singh H, Bhushan S, Yadav MK, Velpandian T, et al. Vitreous substitutes: An overview of the properties, importance, and development. J Biomed Mater Res B Appl Biomater. 2021;109(8):1156–76.
  7. Asensio-Sánchez VM, Collazos JM, Cantón M. Concentración de interleuquina-6 en el vítreo de pacientes con desprendimiento de retina. Arch Soc Esp Oftalmol. 2015;90(11):527–30.
  8. Garweg JG, Zandi S, Pfister I, Rieben R, Skowronska M, Tappeiner C. Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment. Acta Ophthalmol. 2019;97(4).
  9. Versura P, Cellini M, Torreggiani A, Bernabini B, Rossi A, Moretti M, et al. The Biocompatibility of Silicone, Fluorosilicone and Perfluorocarbon Liquids as Vitreous Tamponades. Ophthalmologica. 2001;215(4):276–83.
  10. Liu Z, Fu G, Liu A. The relationship between inflammatory mediator expression in the aqueous humor and secondary glaucoma incidence after silicone oil tamponade. Exp Ther Med. 2017;
  11. Song J, Chen T, Zuo W, Chen W, Lei M, Ai M. Changes of retinal ganglion cell complex after vitrectomy in rhegmatogenous retinal detachment patients and its correlation with inflammatory blood biomarkers. BMC Ophthalmol. 2022;22(1):290.
  12. Zandi S, Pfister IB, Traine PG, Tappeiner C, Despont A, Rieben R, et al. Biomarkers for PVR in rhegmatogenous retinal detachment. PLoS One. 2019;14(4):e0214674.
  13. Rusnak S, Vrzalova J, Hecová L, Kozova M, Topolcan O, Ricarova R. Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber. Biomark Med. 2013;7(5):759–67.
  14. Pollreisz A, Sacu S, Eibenberger K, Funk M, Kivaranovic D, Zlabinger GJ, et al. Extent of Detached Retina and Lens Status Influence Intravitreal Protein Expression in Rhegmatogenous Retinal Detachment. Investigative Opthalmology & Visual Science. 2015;56(9):5493.
  15. Dai Y, Wu Z, Sheng H, Zhang Z, Yu M, Zhang Q. Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment. Mol Vis. 2015;21:417–27.
  16. Conart J-B, Augustin S, Remen T, Sahel J-A, Guillonneau X, Delarasse C, et al. Vitreous cytokine expression profiles in patients with retinal detachment. J Fr Ophtalmol. 2021;44(9):1349–57.
  17. Zhu C, Cheng Y, Tang Y, Wu H. Changes of aqueous humor cytokine profiles of patients with high intraocular pressure after PPV for retinal detachment. https://www.researchsquare.com/article/rs-3288564/lates. 2023.
  18. Koçak N, Erduran B, Yeter V. Predictive values of systemic inflammation biomarkers in proliferative vitreoretinopathy associated with primary rhegmatogenous retinal detachment. Clin Exp Optom. 2023;106(8):852–8.
  19. Nakazawa T, Kayama M, Ryu M, Kunikata H, Watanabe R, Yasuda M, et al. Tumor Necrosis Factor-α Mediates Photoreceptor Death in a Rodent Model of Retinal Detachment. Investigative Opthalmology & Visual Science. 2011;52(3):1384.
  20. Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, Skondra D, et al. Characterization of cytokine responses to retinal detachment in rats. Mol Vis. 2006;12:867–78.
  21. Prasad M, Xu J, Agranat JS, Xia W, Daley S, Ness S, et al. Upregulation of Neuroinflammatory Protein Biomarkers in Acute Rhegmatogenous Retinal Detachments. Life. 2022;13(1):118.
  22. Shimizu H, Kaneko H, Suzumura A, Takayama K, Namba R, Funahashi Y, et al. Biological Characteristics of Subsilicone Oil Fluid and Differences With Other Ocular Humors. Transl Vis Sci Technol. 2019;8(1).
  23. Kaneko H, Takayama K, Asami T, Ito Y, Tsunekawa T, Iwase T, et al. Cytokine profiling in the sub-silicone oil fluid after vitrectomy surgeries for refractory retinal diseases. Sci Rep. 2017;7(1):2640.

How to Cite

Zulfiana Abidin, A., Budu, Ichsan, A. M. ., Muhiddin, H. S. ., & Eka, H. . (2023). Pro and Anti-Inflammatory Factors in Patients with Rhegmatogenous Retinal Detachment with Silicone Oil Tamponade. Bali Medical Journal, 13(1), 350–355. https://doi.org/10.15562/bmj.v13i1.5067

HTML
6

Total
5

Share

Search Panel